Disclosures: Sandra Torres: Nothing to Disclose, Anna Baulies: Nothing to Disclose, Raquel Fucho: Nothing to Disclose, Susana Nuez: Nothing to Disclose, Antoni Rimola: Nothing to Disclose, Ferran Torres: Nothing to Disclose, Naira Rico: Nothing to Disclose, Joanna Ferrer-Fabrega: Nothing to Disclose, Josep Fuster: Nothing to Disclose, Jose Fernandez-Checa: Nothing to Disclose, Carmen Garcia-Ruiz: Nothing to Disclose 1333 RISK FACTORS AND OUTCOMES OF REJECTION IN LIVER TRANSPLANT RECIPIENTS WITH AUTOIMMUNE LIVER DISEASES: A COMPREHENSIVE ANALYSIS Ahmad Yanis 1 Garren Montgomery 2 Megan Jones 3 Jinyuan Liu 1 Ashley Spann 1 Manhal Izzy 1 , 1 Vanderbilt University Medical Center, 2 Ohio State University Medical Center, 3 Vanderbilt University Background: Autoimmune liver diseases (AILD) including autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC) are common indications for liver transplant (LT)
Estrogen has been found to enhance Survivin gene expression (86, 87), thereby inhibiting both inflammation and apoptosis, an effect that is dependent on ER (87)
This review provided an overview of the correlation between tumor angiogenesis and drug resistance development in breast cancer, as well as methods for reversing drug resistance via anti-angiogenic therapy
Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: is there a common mechanism
Benefits There are several advantages of utilizing BACA PURE FILTRATION in stone fabrication applications
